Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting and preventing autoimmunity, myth or reality?

Michal Harel1, Yehuda Shoenfeld

  • 1Center for Autoimmune Diseases, Department of Medicine B, Sheba Medical Center, Tel-Aviv University, Tel-Hashomer 52621, Israel.

Annals of the New York Academy of Sciences
|July 21, 2006
PubMed
Summary

Predicting autoimmune diseases years before symptoms is possible by detecting autoantibodies in healthy individuals. Early detection allows for timely interventions to prevent severe manifestations and treat autoimmune conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging the gap: A systematic approach to integrating serum and plasma proteomic datasets for biomarker studies.

Journal of pharmaceutical and biomedical analysis·2026
Same author

PD-1 Blockade-Induced DKK1 Expression by CD8+ T Cells Promotes Blood-Brain Barrier Permeabilization.

Cancer discovery·2026
Same author

Sirt6 prevents the age-related decline of H<sub>2</sub>S through the control of one-carbon metabolism.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

CGE25-111: Enhancing Oncology Treatment Personalization through Plasma Proteomics and Machine Learning.

Journal of the National Comprehensive Cancer Network : JNCCN·2025
Same author

Mesenchymal stem cell-derived exosomes mitigate amyloid β-induced retinal toxicity: Insights from rat model and cellular studies.

Journal of extracellular biology·2025
Same author

Impact of PROphet Test in Changing Physicians' Therapeutic Decision-Making for Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer.

Clinical lung cancer·2024

Area of Science:

  • Immunology
  • Endocrinology
  • Rheumatology

Background:

  • Autoimmune diseases are chronic conditions often preceded by detectable autoantibodies.
  • Examples include islet cell antibodies (ICA) for diabetes mellitus, anti-CCP for rheumatoid arthritis (RA), and antibodies in systemic lupus erythematosus (SLE).
  • These autoantibodies can appear years before clinical symptoms manifest.

Purpose of the Study:

  • To explore the potential of screening healthy individuals for autoantibodies.
  • To highlight the prospect of predicting and preventing autoimmune diseases.
  • To discuss the importance of early detection for preventing severe manifestations and enabling treatment.

Main Methods:

  • Review of existing literature on autoantibody detection preceding autoimmune diseases.

Related Experiment Videos

  • Analysis of the time course of autoantibody development in conditions like diabetes mellitus, RA, SLE, antiphospholipid syndrome, primary biliary cirrhosis (PBC), and autoimmune thyroid diseases (AITD).
  • Examination of potential therapeutic interventions based on early autoantibody detection.

    • Main Results:

    • Autoantibodies consistently precede the clinical onset of various autoimmune diseases by months to years.
    • Screening for autoantibodies offers a window for early intervention.
    • Specific treatments like aspirin, ursodeoxycholic acid, and vitamin D show promise in managing or preventing autoimmune conditions.

    Conclusions:

    • The detection of autoantibodies in healthy individuals presents a significant opportunity for predicting and potentially preventing autoimmune diseases.
    • Early diagnosis through autoantibody screening can avert life-threatening complications and allow for proactive treatment strategies.
    • Further research is needed to optimize screening protocols and treatment efficacy for autoimmune prediction and prevention.